AmpleLogic Turns 15; Marked in an Evening Filled with Celebrations and Inspiration
HYDERABAD, India, July 22, 2024 /PRNewswire/ -- AmpleLogic, a leader in providing GAMP (Good Automated Manufacturing Practices) solutions, celebrated its 15th anniversary with a grand event on July 19, 2024, at Sandhya Convention, Hyderabad. The evening was filled with inspiring speeches, captivating dance performances, and a fashion show highlighting the company's journey...
Gan & Lee Pharmaceuticals’ Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial
Obese and overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean percent changes in body weight from baseline of -11.15%, -13.22%, -14.25%, -17.29%, and -17.78%, respectively, with the placebo group at -0.99%; and at 30...
Hong Kong Seeing Dog Service（HKSEDS）6th Charity Golf Tournament 2024
" Lighting up life with youngsters and elderlies" 2024 HONG KONG, July 22, 2024 /PRNewswire/ -- 10 July 2024（Wed）Hong Kong Seeing Dog Service（HKSEDS）hosted 6th Charity Golf Tournament 2024 at the Hong Kong Golf Club (Fanling) goes smoothly. The purpose of this charity event is to raise funds for the center to extend regular guide dog services to companion dogs. The service...
QingSong Health and Globethics Announce Strategic Partnership
BEIJING, July 22, 2024 /PRNewswire/ -- QingSong Health, a leading health technology platform based in China, has announced a strategic partnership with Globethics, en international leading organization on ethical leadership based in Geneva, Switzerland. This collaboration is set to push forward the ethical use of AI technology in healthcare, promote education on philanthropic ethics, and enhance global collaboration on...
Duke-NUS launches LIVE Ventures, a S$20 million incubator to accelerate research commercialisation
New incubator aims to tap industry experts to bridge the knowledge and funding gap to enhance bench-to-bedside success LIVE Ventures provides up to $500,000 for high-potential academic research projects SINGAPORE, July 22, 2024 /PRNewswire/ -- Duke-NUS Medical School today launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative academic research. Focused...
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit
SINGAPORE, July 22, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) today announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT). Agilent launches new ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia...
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis
SHANGHAI, July 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the first Chinese patient has been dosed with zetomipzomib in the global Phase 2b PALIZADE trial for the treatment of active lupus nephritis (LN). Zetomipzomib is a...
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA
SAN FRANCISCO and SUZHOU, China, July 22, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that the Phase 3 clinical trial (DREAMS-1) of mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1 receptor...
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors
HEIDELBERG, Germany and GEMBLOUX, Belgium and SHANGHAI, China, July 22, 2024 /PRNewswire/ -- Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced the appointment of Ted Myles to Full-Life's Board of Directors. Mr. Myles will serve as chairman of the audit committee and as a member of the compensation committee of the Board. "We are pleased to welcome Ted...
Infinitus Earns Prestigious Mercer China Healthiest Workplace Title and the Outstanding Health Innovation Award
GUANGZHOU, China, July 20, 2024 /PRNewswire/ -- On July 18th, as the 2024-2025 Mercer China Healthiest Workplace List was unveiled, Infinitus received the prestigious "Mercer China Healthiest Workplace" designation and the Outstanding Health Innovation Award. Infinitus Honored with the Mercer China Healthiest Workplace Title and the Outstanding Health Innovation Award The Mercer China Healthiest Workplace Awards...
